Development of AWZ1066S, a Small Molecule Anti-Wolbachia Candidate Macrofilaricide Drug
Latest Information Update: 26 Sep 2023
At a glance
- Drugs AWZ 1066 S (Primary)
- Indications Filariasis; Onchocerciasis
- Focus Adverse reactions; First in man
- Acronyms AWOL
- 19 Sep 2023 Status changed from not yet recruiting to discontinued due to safety issues.
- 25 Oct 2021 New trial record